Xia Tingwei, Yang Yue, Li Weihong, Tang Zhaohui, Li Zongrun, Guo Yongsong
Basic Medical College.
School of Clinical Medicine, Chengdu University of TCM, Chengdu, Sichuan Province, China.
Medicine (Baltimore). 2019 May;98(19):e15639. doi: 10.1097/MD.0000000000015639.
Type 2 diabetes is one of the most common and complex chronic disease. A lot of clinical researches have focused on meditative movement for type 2 diabetes. However, there is no systematic review and meta-analysis has been conducted. We aim to systematically review the effect of meditative movement on the type 2 diabetes care.
The databases including PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, Ovid LWW, EMBASE will be searched. Studies published from the time when the database establishment to December 2018 will be retrieved. RCTs study on meditative movement for glucose control in patients with type 2 diabetes will be included. The primary outcomes are HbA1c, fasting blood glucose, and postprandial blood glucose (PPBG). RevMan V.5.3 software will be used to perform the analyses.
This study will provide high-quality synthesis of effectiveness and safety of meditation movement for type 2 diabetes.
This systematic review will provide high-quality evidence to judge whether the meditative movement is beneficial to glucose control in patients with type 2 diabetes.PROSPERO registration number: CRD42019128495.
2型糖尿病是最常见且复杂的慢性病之一。许多临床研究聚焦于冥想运动对2型糖尿病的影响。然而，尚未进行系统评价和荟萃分析。我们旨在系统评价冥想运动对2型糖尿病护理的效果。
检索包括PubMed、Cochrane对照试验中心注册库（CENTRAL）、科学网、Ovid LWW、EMBASE在内的数据库。检索自建库至2018年12月发表的研究。纳入关于冥想运动对2型糖尿病患者血糖控制的随机对照试验研究。主要结局指标为糖化血红蛋白、空腹血糖和餐后血糖（PPBG）。将使用RevMan V.5.3软件进行分析。
本研究将提供关于冥想运动对2型糖尿病有效性和安全性的高质量综合分析。
本系统评价将提供高质量证据，以判断冥想运动是否有利于2型糖尿病患者的血糖控制。
CRD42019128495。
